Here, we report for the first time that increased expression of PRKCSH in lung cancers is associated with loss of NK cell-mediated antitumor effects via adaptation to the TNFSF response, as clearly evidenced by the results of various experiments on tumor sphere formation, cell death, and in vivo tumorigenesis. This evidence concerns the gene PRKCSH and neoplasm.